Finance

Beta
Lists
300482:SHE
Guangzhou Wondfo Biotech Co Ltd
CN¥18.49
+15.06%
(+2.42) 1D
Jun 5, 3:04:34 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300482...
Open
CN¥16.35
High
CN¥18.80
Low
CN¥16.35
Mkt. cap
7.52B
Avg. vol.
6.53M
Volume
26.56M
Dividend
1.19%
Quarterly dividend
CN¥0.05
Ex-dividend date
Jun 2, 2026
52-wk high
CN¥26.29
52-wk low
CN¥16.00
EPS
-CN¥0.33
Shares outstanding
468.09M
No. of employees
2K
Open
CN¥16.35
High
CN¥18.80
Low
CN¥16.35
Mkt. cap
7.52B
Avg. vol.
6.53M
Volume
26.56M
Dividend
1.19%
Quarterly dividend
CN¥0.05
Ex-dividend date
Jun 2, 2026
52-wk high
CN¥26.29
52-wk low
CN¥16.00
EPS
-CN¥0.33
Shares outstanding
468.09M
No. of employees
2K
News stories
From sources across the web
About Guangzhou Wondfo Biotech Co Ltd
CEO-
Employees2.44K
FoundedNov 13, 1992
Headquarters-
SectorMedical device
Websitewondfo.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
445.38M
444.52M
396.65M
581.74M
Cost of goods sold
191.64M
212.69M
238.24M
213.83M
Cost of revenue
191.64M
212.69M
238.24M
213.83M
Research and development expenses
71.12M
90.88M
71.60M
73.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
198.95M
220.15M
327.80M
177.81M
Operating expense
267.51M
310.42M
396.37M
267.63M
Total operating expenses
459.15M
523.11M
634.61M
481.47M
Operating income
-13.77M
-78.59M
-237.96M
100.28M
Other non operating income
-5.00M
-9.71M
7.75M
-13.32M
EBT including unusual items
-10.24M
-78.16M
-241.31M
97.18M
EBT excluding unusual items
-19.34M
-87.55M
-224.63M
84.28M
Income tax expense
-10.38M
-14.38M
-45.22M
11.06M
Effective tax rate
101.34%
18.40%
18.74%
11.38%
Other operating expenses
1.79M
2.04M
3.96M
8.28M
Net income
63.53K
-55.46M
-196.76M
84.40M
Net profit margin
0.01%
-12.48%
-49.61%
14.51%
Earnings per share
-
-
-
-
Interest and investment income
10.11M
6.67M
28.80M
4.76M
Interest expense
-7.72M
-8.89M
-7.00M
-7.45M
Net interest expenses
2.39M
-2.22M
21.80M
-2.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
40.13M
-26.98M
-181.85M
156.39M
Gain or loss from assets sale
2.09K
-2.09K
-318.79K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer